We worked with MassHealth, the Massachusetts Medicaid program, to establish and organize a stakeholder engagement process that informed the development and implementation of a 1115 Medicaid waiver, which shifted MassHealth to a value-based delivery system using Accountable Care Organizations.

Our approach to dual eligible data analytics led to MassHealth, the Massachusetts Medicaid program, saving over $68 million through benefits optimization and recovering over $21 million in Medicare premium overpayments. 

This study, conducted by researchers from the Center for Health Policy and Research, evaluates the impact of practice participation in a pediatric patient-centered medical home learning collaborative on preventable emergency department visits among children in MassHealth.

This brief, compiled by experts from our Center for Health Law and Economics, goes over the basics of MassHealth's introduction of Accountable Care Organizations (ACOs). It includes a brief introduction of what an ACO is, the three distinct types of ACOs, who they serve, the services they provide and how they can improve care and contain costs.

Our researchers and pharmacists set out to find out how well Ledipasvir/sofosbuvir worked in treating Hepatitis C virus in a Medicaid population. They found the treatment was largely successful in creating a sustained viral response, which was achieved in 95% of members.

In an Op-Ed piece for CommonWealth magazine, Warren J. Ferguson of the Health and Criminal Justice Program provides

real world examples of how methadone has proven it's efficacy in other states and why this treatment needs to be offered to all incarcerated persons, including those in Massachusetts, with substance us disorder.

A team from our Center for Health Policy and Research dig into data on Social Security Disability Insurance and Supplementary Security Income across the United States. Their findings strongly suggest geographic variation in program participation is most likely a result of socioeconomic differences and disability prevalence.

A case study on MassOptions, a free online and telephonic service that simplifies access to LTSS for the elderly, individuals with disabilities and their caregivers in Massachusetts. MassOptions is supported by the multidisciplinary team of UMass Medical School, UHealthSolutions, the Executive Office of Elder Affairs and Community Partners. 

This poster gives an overview of pulmonary exacerbation rates pre- and post-initiation of Lumacaftor/Ivacaftor (LUM/IVA) in Massachusetts' Medicaid program. Before this study, there had been no published data evaluating real-world outcomes for Medicaid patients receiving this therapy.